Advertisement
Advertisement
OMIC
Singular Genomics Systems Inc
20.15
USD+0.44
+2.23%
Dec 18, 11:17 UTC -5
Closed
...
Singular Genomics Systems Inc Profile
About
Info & Links
CEO
Andrew Spaventa
Headquarters
SAN DIEGO, CA 92121, UNITED STATES
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
63
Employees
265
Singular Genomics Systems Inc Statistics
Valuation Measures
Market Capitalization2
50.58M
Enterprise Value
3.12M
Enterprise Value/EBITDA(ttm)
-0.04
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
18.84
Price to Book(mrq)
0.40
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
-58.84%
Operating Margin(ttm)
-3237.89%
Profit Margin(ttm)
-3708.20%
Return on Equity(ttm)
-57.87%
Return on Invested Capital(ttm)
-55.43%
Return on Assets(ttm)
-37.90%
Income Statement
Revenue(ttm)
2.67M
Revenue Per Share(ttm)
1.06
Gross Profit(ttm)
-1.35M
EBITDA(ttm)3
-88.33M
Net Income Available to Common(ttm)
-86.32M
Diluted EPS(ttm)
-35.11
Share Statistics
Beta (5Y Monthly)
1.82
52-Week Change
56.24%
S&P 500 52-Week Change
23.87%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
2.51M
Dividend Yield
0.00%
Float4
1.95M
% Held by Insiders
22.20%
% Held by Institutions
65.80%
Balance Sheet
Total Cash(mrq)
113.83M
Total Cash Per Share(mrq)
45.32
Total Debt(mrq)
5.17M
Total Debt/Equity(mrq)
4.19%
Current Ratio(mrq)
7.37%
Quick Ratio(mrq)
6.67%
Book Value Per Share(mrq)
49.16
Cash Flow
Operating Cash Flow Per Share(ytd)
-24.60
Free Cash Flow(ytd)
-61.56M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement